Fragasso Group Inc. Pfizer Inc Transaction History

Fragasso Group Inc.

$1.24 Billion
Q3 2024

A detailed history of Fragasso Group Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Fragasso Group Inc. holds 22,704 shares of PFE stock, worth $604,380. This represents 0.05% of its overall portfolio holdings.

Number of Shares

22,704

Previous 29,344 22.63%

Holding current value

$604,380

Previous $821,000 19.98%

% of portfolio

0.05%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$27.7 - $31.39 $183,928 - $208,429	-6,640 Reduced 22.63%	22,704 $657,000
Q2 2024 Jul 08, 2024	SELL	$25.26 - $29.6 $172,197 - $201,783	-6,817 Reduced 18.85%	29,344 $821,000
Q1 2024 Apr 10, 2024	SELL	$25.89 - $29.73 $34,200 - $39,273	-1,321 Reduced 3.52%	36,161 $1 Million
Q4 2023 Jan 08, 2024	BUY	$26.13 - $33.94 $30,598 - $39,743	1,171 Added 3.22%	37,482 $1.08 Million
Q3 2023 Dec 06, 2023	SELL	$32.09 - $37.51 $111,384 - $130,197	-3,471 Reduced 8.73%	36,311 $1.2 Million
Q2 2023 Jul 10, 2023	BUY	$36.12 - $41.79 $12,569 - $14,542	348 Added 0.88%	39,782 $1.46 Million
Q1 2023 Apr 13, 2023	SELL	$39.39 - $51.28 $25,997 - $33,844	-660 Reduced 1.65%	39,434 $1.61 Million
Q4 2022 Jan 24, 2023	SELL	$41.75 - $54.5 $33,734 - $44,036	-808 Reduced 1.98%	40,094 $0
Q4 2022 Jan 24, 2023	SELL	$41.75 - $54.5 $1.67 Million - $2.19 Million	-40,094 Closed	0 $0
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $117,889 - $143,913	-2,694 Reduced 6.18%	40,902 $1.79 Million
Q2 2022 Aug 30, 2022	BUY	$46.53 - $55.17 $40,946 - $48,549	880 Added 2.06%	43,596 $2.29 Million
Q1 2022 Apr 06, 2022	SELL	$45.75 - $56.69 $53,527 - $66,327	-1,170 Reduced 2.67%	42,716 $2.21 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $153,338 - $227,298	-3,711 Reduced 7.8%	43,886 $2.59 Million
Q3 2021 Oct 08, 2021	SELL	$39.25 - $50.42 $1.71 Million - $2.2 Million	-43,650 Reduced 47.84%	47,597 $2.05 Million
Q2 2021 Jul 19, 2021	SELL	$35.91 - $40.68 $1.42 Million - $1.61 Million	-39,467 Reduced 30.19%	91,247 $3.57 Million
Q1 2021 May 27, 2021	BUY	$33.49 - $37.77 $344,813 - $388,879	10,296 Added 8.55%	130,714 $4.74 Million
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $521,931 - $663,680	15,594 Added 14.88%	120,418 $4.43 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $101,441 - $119,013	3,195 Added 3.14%	104,824 $3.85 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $359,783 - $436,470	11,945 Added 13.32%	101,629 $3.91 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $121,418 - $173,481	4,492 Added 5.27%	89,684 $2.93 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $148,008 - $167,970	4,496 Added 5.57%	85,192 $3.34 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $107,866 - $139,871	3,320 Added 4.29%	80,696 $2.9 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $174,064 - $195,434	4,707 Added 6.48%	77,376 $3.35 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $539,925 - $593,197	14,398 Added 24.71%	72,669 $3.09 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $25,467 - $29,035	-662 Reduced 1.12%	58,271 $2.54 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $226,226 - $274,399	6,563 Added 12.53%	58,933 $2.6 Million
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $3,034 - $3,234	92 Added 0.18%	52,370 $1.9 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $7,052 - $8,181	-221 Reduced 0.42%	52,278 $1.86 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $167,098 - $177,296	5,024 Added 10.58%	52,499 $1.9 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $223,789 - $246,528	-7,219 Reduced 13.2%	47,475 $1.7 Million
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $1.7 Million - $1.87 Million	54,694	54,694 $1.99 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.

Account

Fragasso Group Inc. Pfizer Inc Transaction History